Back to search

Article

Developing a Stepwise Induction Protocol for Cisplatin-Resistant Human Cervical Cancer Cells

2025-11-21

Abstract excerpt

Cisplatin, a platinum-based DNA crosslinking chemotherapeutic, remains the cornerstone of first-line chemoradiation therapy for advanced cervical cancer. However, the clinical efficacy of cisplatin is frequently compromised by the emergence of acquired resistance, which represents a principal cause of treatment failure and disease recurrence. Traditional protocols for generating resistant cervical cancer cell line...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3bf39da3-8ea0-5a39-835f-7cd8c066b350
DOI
10.1101/2025.11.20.687683
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Developing a Stepwise Induction Protocol for Cisplatin-Resistant Human Cervical Cancer CellsDOI 10.1101/2025.11.20.687683
Select a neighboring publication to make it the new centre.